Effect of mitoxantrone therapy on T1 lesion load and atrophy in multiple sclerosis patients

Effect of mitoxantrone therapy on T1 lesion load and atrophy in multiple sclerosis patients

Bibliographic Details
Main Authors:	Walczak, A, Berkowicz, T, Wartolowska, K, Siger, M, Zaleski, K, Selmaj, K
Format:	Conference item
Published:	2006

Similar Items

A multiple sclerosis case with predominant cortical lesions
by: Berkowicz, T, et al.
Published: (2005)

Running a mitoxantrone service for multiple sclerosis
by: Craner, M, et al.
Published: (2006)

Sex-related differences in atrophy and lesion load in multiple sclerosis patients
by: J.I. Rojas, et al.
Published: (2013-09-01)

The impact of mitoxantrone on neurological disability in active multiple sclerosis patients
by: Mesaroš Šarlota, et al.
Published: (2004-01-01)

Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany
by: Anke Stroet, et al.
Published: (2012-03-01)

Mitoxantrone in the treatment of multiple sclerosis: a single-center experience
by: Özlem Taşkapılıoğlu, et al.
Published: (2012-06-01)

Brain atrophy and lesion load predict long term disability in multiple sclerosis.
by: Popescu, V, et al.
Published: (2013)

Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis
by: Tobias Zrzavy, et al.
Published: (2021-07-01)

The paced auditory serial addition test in multiple sclerosis patients: the effect of brain atrophy and T1 lesion load
by: Kazis Dimitrios, et al.
Published: (2006-02-01)

A case of Marburg's variant of multiple sclerosis successfully treated with IVIg and mitoxantrone
by: Adarsh Manuel, et al.
Published: (2021-01-01)

Corrigendum to “Rituximab mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis”
Published: (2021-09-01)

Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
by: Coralie Chanvillard, et al.
Published: (2012-01-01)

Mitoxantrone in secondarily progressive multiple sclerosis: a series of 18 patients Mitoxantrone na esclerose múltipla secundária progressiva relato de 18 casos
by: María Belén Montú, et al.
Published: (2005-06-01)

Thalamus Atrophy in the Peri-Pregnancy Period in Clinically Stable Multiple Sclerosis Patients: Preliminary Results
by: Iwona Rościszewska-Żukowska, et al.
Published: (2021-09-01)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
by: Vrenken, H, et al.
Published: (2013)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
by: Vrenken, H, et al.
Published: (2013)

Impairment of visuospatial/visuoconstructional skills in multiple sclerosis patients: the correlation with regional lesion load and subcortical atrophy
by: R. Marasescu, et al.
Published: (2016-04-01)

Combination therapy with mitoxantrone and plasma exchange in aggressive relapsing remitting multiple sclerosis: A preliminary clinical study
by: Nasim Tabrizi, et al.
Published: (2012-01-01)

Increased brain atrophy and lesion load is associated with stronger lower alpha MEG power in multiple sclerosis patients
by: Van Schependom, J, et al.
Published: (2021)

Increased brain atrophy and lesion load is associated with stronger lower alpha MEG power in multiple sclerosis patients
by: Jeroen Van Schependom, et al.
Published: (2021-01-01)

Impact of Diminished Expression of circRNA on Multiple Sclerosis Pathomechanisms
by: Marcin P. Mycko, et al.
Published: (2022-06-01)

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis
by: Monika Grudziecka Pyrek, et al.
Published: (2022-09-01)

Use of Mitoxantrone in Early Secondary Progressive Multiple Sclerosis: An Observational Study of 48 Patients with Clinical and MRI Outcomes
by: Ahmet Kasım Kılıç, et al.
Published: (2009-06-01)

Mitoxantrone and Mitoxantrone-Loaded Iron Oxide Nanoparticles Induce Cell Death in Human Pancreatic Ductal Adenocarcinoma Cell Spheroids
by: Jonas Dinter, et al.
Published: (2023-04-01)

Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis
by: Ting‐Yi Lin, et al.
Published: (2024-01-01)

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis
by: Peter Rieckmann, et al.
Published: (2012-01-01)

Does physical exercise improve or deteriorate treatment of multiple sclerosis with mitoxantrone? Experimental autoimmune encephalomyelitis study in rats
by: Mohamed A. El-Emam, et al.
Published: (2022-03-01)

Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy
by: Samuel Klistorner, et al.
Published: (2022-10-01)

Brain atrophy: an in-vivomeasure of disease activity in multiple sclerosis
by: Ernst Wilhelm Radü, et al.
Published: (2013-11-01)

Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis
by: Magdalena Oset, et al.
Published: (2023-07-01)

Measuring brain atrophy in multiple sclerosis.
by: De Stefano, N, et al.
Published: (2007)

Mitoxantrone-induced neurotoxicity in CD-1 mice
by: Ana Dias-Carvalho, et al.
Published: (2022-04-01)

Optical Coherence Tomography in the Differential Diagnosis of Patients with Multiple Sclerosis and Patients with MRI Nonspecific White Matter Lesions
by: Małgorzata Siger, et al.
Published: (2021-10-01)

Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions.
by: Evangelou, N, et al.
Published: (2005)

Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions
by: Evangelou, N, et al.
Published: (2005)

Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability
by: Matthias Bussas, et al.
Published: (2022-01-01)

Gray matter atrophy in multiple sclerosis despite clinical and lesion stability during natalizumab treatment.
by: Fredrika Koskimäki, et al.
Published: (2018-01-01)

Polymeric mixed micelles loaded mitoxantrone for overcoming multidrug resistance in breast cancer via photodynamic therapy
by: Li ZY, et al.
Published: (2017-09-01)

Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011)

Grey matter atrophy in patients with benign multiple sclerosis
by: Marja Niiranen, et al.
Published: (2022-07-01)